Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:activities |
inhibits von Willebrand factor
|
| gptkbp:appointed_by |
subcutaneous injection
|
| gptkbp:approves |
gptkb:legislation
gptkb:2018 gptkb:United_States |
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:developed_by |
gptkb:Ablynx
|
| https://www.w3.org/2000/01/rdf-schema#label |
Caplacizumab
|
| gptkbp:is_used_for |
treatment of acquired thrombotic thrombocytopenic purpura
|
| gptkbp:traded_on |
gptkb:Cablivi
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|